At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antidepressants; Antihyperglycaemics
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetes mellitus; Major depressive disorder
Most Recent Events
- 28 Sep 1998 Discontinued-Preclinical for Depression in United Kingdom (Unknown route)
- 28 Sep 1998 Discontinued-Preclinical for Diabetes mellitus in United Kingdom (Unknown route)
- 14 Aug 1996 Preclinical development for Depression in United Kingdom (Unknown route)